The development of therapies for ischemic stroke requires a deep understanding of the immune response to injury. Analysis now defines immune cell origin, disease stage-specific responses, and the effects of age and sex after ischemic stroke.
References
Garcia-Bonilla, L. et al. Nat. Immunol. https://doi.org/10.1038/s41590-023-01711-x (2024).
Iadecola, C., Buckwalter, M. S. & Anrather, J. J. Clin. Invest. 130, 2777–2788 (2020).
Zheng, K. et al. J. Cereb. Blood Flow Metab. 42, 56–73 (2022).
Beuker, C. et al. Nat. Commun. 13, 945 (2022).
Li, X. et al. J. Neuroinflammation 19, 83 (2022).
Qiu, M. et al. Aging Dis. 13, 1436–1454 (2022).
Kierdorf, K., Masuda, T., Jordao, M. J. C. & Prinz, M. Nat. Rev. Neurosci. 20, 547–562 (2019).
Gerganova, G., Riddell, A. & Miller, A. A. Pharmacol. Ther. 240, 108220 (2022).
Cai, W. J. Clin. Invest. 132, e157678 (2022).
Androvic, P. et al. Cell Rep. 31, 107777 (2020).
Ritzel, R. M. et al. Acta Neuropathol 136, 89–110 (2018).
Tsai, A. S. et al. Brain 142, 978–991 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors have no competing interests.
Rights and permissions
About this article
Cite this article
Jiang, D., McCullough, L. Mapping brain–immune interactions in ischemic stroke. Nat Immunol 25, 396–398 (2024). https://doi.org/10.1038/s41590-024-01747-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-024-01747-7
- Springer Nature America, Inc.